JP2025506341A5 - - Google Patents
Info
- Publication number
- JP2025506341A5 JP2025506341A5 JP2024542023A JP2024542023A JP2025506341A5 JP 2025506341 A5 JP2025506341 A5 JP 2025506341A5 JP 2024542023 A JP2024542023 A JP 2024542023A JP 2024542023 A JP2024542023 A JP 2024542023A JP 2025506341 A5 JP2025506341 A5 JP 2025506341A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- ids
- sequence ids
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306434P | 2022-02-03 | 2022-02-03 | |
| US63/306,434 | 2022-02-03 | ||
| US202263370025P | 2022-08-01 | 2022-08-01 | |
| US63/370,025 | 2022-08-01 | ||
| US202263383736P | 2022-11-15 | 2022-11-15 | |
| US63/383,736 | 2022-11-15 | ||
| PCT/US2023/061932 WO2023150677A2 (en) | 2022-02-03 | 2023-02-03 | Anti-cd38 binding molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506341A JP2025506341A (ja) | 2025-03-11 |
| JP2025506341A5 true JP2025506341A5 (https=) | 2026-02-18 |
Family
ID=87552976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542023A Pending JP2025506341A (ja) | 2022-02-03 | 2023-02-03 | 抗ｃｄ３８結合分子及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250051473A1 (https=) |
| EP (1) | EP4473017A2 (https=) |
| JP (1) | JP2025506341A (https=) |
| KR (1) | KR20240139079A (https=) |
| AU (1) | AU2023216348A1 (https=) |
| CA (1) | CA3240270A1 (https=) |
| GE (1) | GEAP202416592A (https=) |
| IL (1) | IL313350A (https=) |
| MX (1) | MX2024009615A (https=) |
| WO (1) | WO2023150677A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3355913B1 (en) | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| WO2026085050A1 (en) | 2024-10-15 | 2026-04-23 | Immunitybio, Inc. | Dual-specific binding molecule useful for isolating specific blood cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE496944T1 (de) * | 2003-07-21 | 2011-02-15 | Immunogen Inc | Ca6-antigenspezifisches zytotoxisches konjugat und verfahren zu dessen anwendung |
| US9603927B2 (en) * | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| MY194669A (en) * | 2016-03-31 | 2022-12-12 | Ngm Biopharmaceuticals Inc | Binding Proteins and Methods of use Thereof |
| MX2019011986A (es) * | 2017-04-07 | 2019-11-07 | Igm Biosciences Inc | Regiones constantes de igm humana modificadas para la modulacion de la funcion efectora de la citolisis dependiente de complemento referencia cruzada a solicitudes relacionadas. |
| PH12021552586A1 (en) * | 2019-04-17 | 2023-07-31 | Novo Nordisk As | Bispecific antibodies |
-
2023
- 2023-02-03 AU AU2023216348A patent/AU2023216348A1/en active Pending
- 2023-02-03 CA CA3240270A patent/CA3240270A1/en active Pending
- 2023-02-03 KR KR1020247028900A patent/KR20240139079A/ko active Pending
- 2023-02-03 JP JP2024542023A patent/JP2025506341A/ja active Pending
- 2023-02-03 WO PCT/US2023/061932 patent/WO2023150677A2/en not_active Ceased
- 2023-02-03 IL IL313350A patent/IL313350A/en unknown
- 2023-02-03 GE GEAP202416592A patent/GEAP202416592A/en unknown
- 2023-02-03 US US18/719,191 patent/US20250051473A1/en active Pending
- 2023-02-03 EP EP23750434.5A patent/EP4473017A2/en active Pending
-
2024
- 2024-08-02 MX MX2024009615A patent/MX2024009615A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7551693B2 (ja) | ＮＫｐ４６結合タンパク質の可変領域 | |
| TWI743461B (zh) | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 | |
| JP2022545655A5 (https=) | ||
| TW201803899A (zh) | 三特異性和／或三價結合蛋白 | |
| TW201833141A (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| US20220289856A1 (en) | Multimeric bispecific anti-cd123 binding molecules and uses thereof | |
| AU2018214223A1 (en) | Low pH pharmaceutical composition comprising T cell engaging antibody constructs | |
| US11932704B2 (en) | Trispecific and/or trivalent binding proteins | |
| US20220119525A1 (en) | Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3 | |
| JP2025506341A5 (https=) | ||
| JP2023538117A (ja) | 神経免疫疾患のためのｃｄ３／ｃｄ２５抗体 | |
| KR20240031229A (ko) | 알파-시누클레인병증 치료용 항체 | |
| JP2024509274A (ja) | Ｃｄ３及びｇｐｃ３に結合するヘテロ二量体抗体 | |
| US20250122299A1 (en) | ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES | |
| JP2025526279A (ja) | 抗ＴＮＦα抗体および組成物 | |
| KR20250169614A (ko) | 최적화된 cd3 항원 결합 도메인 | |
| IL323855A (en) | Steap2 directed t-cell engagers and compositions thereof | |
| KR20250148649A (ko) | 항-muc17*cd3*cd28 삼중 특이성 항체 | |
| JP2026500710A (ja) | 二重特異性タンパク質を製造する方法 | |
| KR102240802B1 (ko) | 교차 결합 영역 배향을 갖는 이원 가변 영역 항체-유사 결합 단백질 | |
| CN121219320A (zh) | 针对il12受体的双特异性激动性抗体 | |
| EA052893B1 (ru) | Антигенсвязывающая молекула, специфически связывающаяся с rankl и ngf, и ее применение в медицине | |
| NZ616174B2 (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation | |
| HK1194744B (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation |